BECOME A MEMBER - Get Unlimited CE

  • SIGN IN
  • GET HELP
    •  

    Webinar Details

    Event Type

    Live Online

    Date

    Wednesday, August 28, 2024

    Time

    6:00 PM - 7:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      This course will explain in brief the mechanism of action and some ADA Guidelines for use of some of the newest agents to treat type 2 diabetes: the SGLTs and the GLPs Some of the most robust studies will be outlined, but the course is meant to give a brief, simple synopsis of these groundbreaking therapies.


      Handouts

      Slide Document 22274L01_2pp.pdf
      Slide Document 22274L01_6pp.pdf





      Financial Support By

      PharmCon

    • Pharmacist

      Identify the current ADA guidelines on the management of type 2 diabetes with GLP-1s and SGLT-2s
      Recognize the appropriate patient who may be a candidate for SGLT-2s vs. GLP-1s
      Identify the contraindications for prescribing GLP-1s and SGLT-2s

      Pharmacy Technician

      Identify the current ADA guidelines on the management of type 2 diabetes with GLP-1s and SGLT-2s
      Recognize the appropriate patient who may be a candidate for SGLT-2s vs. GLP-1s
      Identify the contraindications for prescribing GLP-1s and SGLT-2s

      Nurse

      Recognize the appropriate patient who may be a candidate for SGLT-2s vs. GLP-1s
      Identify the current ADA guidelines on the management of type 2 diabetes with GLP-1s and SGLT-2s
      Identify the contraindications for prescribing GLP-1s and SGLT-2s

    • Repeat Presentation

      This presentation was last given on 8/28/2024 6:00 PM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Knowledge

      CE Broker

      20-952198

      Universal Activity Number

      Pharmacist 0798-0000-22-274-L01-P

      Pharmacy Technician 0798-0000-22-274-L01-T

      Nurse 0798-0000-22-274-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

     

    LEARN

    LIVE CE

    HOME STUDY CE

    NEWS

    SPECIALTY CERTIFICATES

    SUPPORT

    ABOUT

    RESOURCES

    CE REPORTING

    CAREER ASSISTANCE

    PATIENT CARE INFO

     

    CE ACTIVITY

    ACCOUNT

    (843) 488 5550 Office

    (843) 488 5554 Fax

    info@freeCE.com Email

    www.freeCE.com Web

    201 N. King of Prussia Rd, Suite 370
    Radnor, PA 19087     Address


     

    ©  PharmCon All Rights Reserved.

    Terms & Conditions

    Privacy Policy

    freeCE is a division of PharmCon